hexon-chimaeric adenovirus serotype vectors circumvent pre-existing anti-vector immunity 
common viral immune evasion strategy involves mutating viral surface proteins order evade host neutralizing antibodies immune evasion tactics previously intentionally applied development novel viral gene delivery vectors overcome critical problem anti-vector immunity recombinant replication-incompetent adenovirus serotype rad5 vector-based vaccines human immunodeficiency virus type pathogens proved highly immunogenic preclinical studies12 will probably limited high prevalence pre-existing anti-ad5 immunity human populations particularly developing world3- show rad5 vectors can engineered circumvent anti-ad5 immunity constructed novel chimaeric rad5 vectors seven short hypervariable regions hvrs surface ad5 hexon protein replaced corresponding hvrs rare adenovirus serotype ad48 hvr-chimaeric rad5 vectors produced high titres stable serial passages vitro hvr-chimaeric rad5 vectors expressing simian immunodeficiency virus gag proved comparably immunogenic parental rad5 vectors naive mice rhesus monkeys presence high levels pre-existing anti-ad5 immunity immunogenicity hvr-chimaeric rad5 vectors detectably suppressed whereas immunogenicity parental rad5 vectors abrogated data demonstrate functionally relevant ad5-specific neutralizing antibodies focused epitopes located within hexon hvrs moreover studies show recombinant viral vectors can engineered circumvent pre-existing anti-vector immunity removing key neutralizing epitopes surface viral capsid proteins chimaeric viral vectors may important practical implications vaccination gene therapy 
